v3.26.1
Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss - CAD ($)
 6 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Expenses    
Professional fees $ 544,029 $ 742,559
Consulting fees 1,969,358 1,055,643
Stock-based compensation (Notes 17, 20, 23) 12,338,372 169,066
Directors' and officers' consulting fees (Note 23) 509,395 476,499
Insurance expense 141,634 270,570
General and administrative expenses 485,370 790,908
Travel expenses 312,981 166,414
Transfer agent and regulatory fees 308,686 142,080
Depreciation on right-of-use assets (Note 13) 90,449 15,840
Bank fees and interest 35,064 4,730
Accretion expense (Note 15) 87,798 1,418
Interest on loan and debentures (Note 12) 223,775 397
Total Expenses (17,046,911) (3,836,124)
Other Items    
Gain (loss) on change in fair value of derivative liabilities (Note 16) 87,117 (47,412)
Realized gain on sale of short-term investments (Note 7) 861,340
Unrealized gain on change of fair value of investments (Notes 7, 11) 1,032,644
Share of loss on investment in joint venture (Note 9) (82,860)
Share of loss from Associate (Note 12) (28,248)
Loss on debt settlement (98,416)
Taxes and penalties (Note 18) (24,166) (800,000)
Premium on flow-through shares (Note 18) 2,016,543
Reversal of flow-through premium liability (Note 18) 460,974
Interest income (Note 6) 365,492
Foreign exchange loss (118,657) (52,822)
Total Other Income 2,092,662 1,478,867
Net Loss and Comprehensive Loss $ (14,954,249) $ (2,357,257)
Weighted Average Number of Outstanding Shares    
Basic and diluted (Note 22) 12,417,745 2,354,785
Net Loss per Share    
Basic and diluted (Note 22) $ (1.20) $ (1.00)